Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemours (CC) Payables (2016 - 2025)

Chemours (CC) has 12 years of Payables data on record, last reported at $929.0 million in Q4 2025.

  • For Q4 2025, Payables fell 19.64% year-over-year to $929.0 million; the TTM value through Dec 2025 reached $929.0 million, down 19.64%, while the annual FY2025 figure was $929.0 million, 19.64% down from the prior year.
  • Payables reached $929.0 million in Q4 2025 per CC's latest filing, down from $1.0 billion in the prior quarter.
  • Across five years, Payables topped out at $1.3 billion in Q3 2022 and bottomed at $885.0 million in Q3 2023.
  • Average Payables over 5 years is $1.1 billion, with a median of $1.1 billion recorded in 2021.
  • Peak YoY movement for Payables: skyrocketed 62.98% in 2021, then crashed 30.31% in 2023.
  • A 5-year view of Payables shows it stood at $1.1 billion in 2021, then rose by 6.05% to $1.2 billion in 2022, then decreased by 4.21% to $1.2 billion in 2023, then dropped by 0.26% to $1.2 billion in 2024, then decreased by 19.64% to $929.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Payables were $929.0 million in Q4 2025, $1.0 billion in Q3 2025, and $1.0 billion in Q2 2025.